Genetics of familial atypical multiple mole-melanoma (FAMMM) syndrome in the Netherlands: How far have we come?

Bulletin du Cancer

Volumn 85, Issue 7, 1998, Pages 627-630

  Gruis, Nelleke A ^a   Van Der Velden, Pieter A ^a   Bergman, Wilma ^a   Frants, Rune R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Genetics; Melanoma; Nevus

Indexed keywords

ARTICLE; CANCER INCIDENCE; CHROMOSOME 1P; CHROMOSOME 9P; CLINICAL ARTICLE; FAMILIAL CANCER; FEMALE; GENE LOCATION; GENETIC LINKAGE; HUMAN; MALE; MELANOMA; MOLECULAR CLONING; NETHERLANDS;

CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYTOCHROME REDUCTASES; CYTOCHROME-B(5) REDUCTASE; HUMANS; LINKAGE (GENETICS); MELANOMA; NEOPLASM PROTEINS; NEOPLASTIC SYNDROMES, HEREDITARY; NETHERLANDS; PEDIGREE; SKIN NEOPLASMS;

EID: 0031852499     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Bergman W, Van Haeringen A, Went LN. The FAMMM syndrome in the Netherlands. In: Lynch HT, Fusaro RM, eds. Hereditary malignant melanoma, Boca Raton: CRC Press Inc., 1991; 35-52.
2. Bergman W, Gruis NA, Frants RR. The Dutch FAMMM family material: clinical and genetic data. Cytogenet Cell Genet 1992; 59: 161-4.
3. Greene MH, Goldin LR, Clark WH, Lovrien E, Kraemer KH, Tucker MA, et al. Familial cutaneous malignant melanoma: autosomal dominant trait possibly linked to the RH locus. Proc Natl Acad Sci USA 1983; 80: 6071-5.
4. Bale SJ, Dracopoli NC, Tucker MA, Clark WH, Fraser MC, Stanger BZ, et al. Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. N Engl J Med 1989; 320: 1367-72.
5. Van Haeringen A, Bergman W, Nelen MR, Van der Kooij-Meijs E, Hendriksel, Wijnen JT, et al. Exclusion of the dysplastic naevus syndrome (DNS) locus from the short arm of chromosome 1 by linkage studies in Dutch families. Genomics 1989; 5: 61-4.
6. Gruis NA, Bergman W, Frants RR. Locus for susceptibility to melanoma on chromosome 1p. N Engl J Med 1990; 322: 853-4.
7. Cannon-Albright L, Goldgar D, Wright F, Turco A, Jost M, Meyer L, et al. Evidence against the reported linkage of cutaneous melanoma-dysplastic nevus syndrome locus to chromosome 1p36. Am J Hum Genet 1990; 46: 912-8.
8. Nancarrow DJ, Palmer JM, Walters MK, Kerr B, Hafner G, Garske L, et al. Exclusion of the familial melanoma locus (MLM) from the PND/D1S47 regions of chromosome arm 1p in 7 Australian families. Genomics 1992; 12: 18-25.
9. Kefford R, Salmon J, Shaw H, Donald J, McCarthy W. Hereditary melanoma in Australia: variable association with dysplastic naevi and absence of genetic linkage to chromosome 1p. Cancer Genet Cytogenet 1991; 51: 45-55.
10. Fountain JW, Karayiorgou M, Ernstoff MS, Kirkwood JM, Vlock DR, Titus-Ernstoff L, et al. Homozygous deletions within human chromosome band 9p21 in melanoma. Proc Natl Acad Sci USA 1992; 89: 10557-61.
11. Petty EM, Gibson LH, Fountain JW, Bolognia JL, Yang-Feng TL, Housman DE, et al. Molecular definition of a chromosome 9p21 germline deletion in a woman with multiple melanomas and a plexiform neurofibroma: implications for 9p tumor-suppressor gene(s). Am J Hum Genet 1993; 53: 96-104.
12. Cannon-Albright LA, Goldgar DE, Meyer LJ, Lewis CM, Anderson DE, Fountain JW, Hegi ME, et al. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science 1992; 258: 1148-52.
13. Gruis NA, Sandkuijl LA, Weber JL, Van der Zee A, Borgstein AM, Bergman W, et al. Linkage analysis in Dutch familial atypical multiple mole-melanoma (FAMMM) syndrome families. Effect of naevus count. Melanoma Res 1993; 3: 271-7.
14. Gruis NA, Sandkuijl LA, Van der Velden PA, Bergman W, Frants RR. CDKN2 explains part of the clinical phenotype in Dutch familial atypical multiple mole-melanoma (FAMMM) syndrome families. Melanoma Res 1995; 5: 169-77.
15. Bergman W, Gruis NA, Sandkuijl LA, Frants RR. Genetics of seven Dutch familial atypical multiple mole-melanoma syndrome families: a review of linkage results including chromosomes 1 and 9. J Invest Dermatol 1994; 103: 122-5.
16. Nancarrow DJ, Mann GJ, Holland EA, Walker GJ, Beaton SC, Walters MK, et al. Confirmation of chromosome 9p linkage in familial melanoma. Am J Hum Genet 1993; 53: 936-42.
17. MacGeoch C, Newton-Bishop JA, Bataille V, Bishop DT, Frischauf AM, Melon K, et al. Genetic heterogeneity in familial malignant melanoma. Hum Mol Genet 1994; 3: 2195-200.
18. Hille ETM, Van Duijn E, Gruis NA, Rosendaal FR, Bergman W, Vandenbroucke JP. Excess cancer mortality in six Dutch pedigrees with the familial atypical multiple mole-melanoma syndrome from 1830 to 1994. J Invest Dermatol 1998; 110: 700-92.
19. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, et al. A cell cycle regulator potentially involved in genesis of many tumour types. Science 1994; 264: 436-40.
20. Weaver-Feldhaus J, Gruis NA, Neuhausen S, Le Paslier D, Stockert K, Skolnick M, et al. Localization of a putative tumor suppressor gene using homozygous deletions in melanomas. Proc Natl Acad Sci USA 1994; 91: 7563-7.
21. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993; 366; 704-7.
22. Liu Q, Neuhausen S, McClure M, Frye C, Weaver-Feldhaus J, Gruis NA, et al. CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines. Oncogene 1995; 10: 1061-7.
23. Gruis NA, Weaver-Feldhaus J, Liu Q, Frye C, Eeles R, Orlow I, et al. Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppression. Am J Pathol 1995; 146: 1-8.
24. Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W, et al. Analysis of the p16 (CDKN2) gene as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet 1994; 8: 22-6.
25. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PAT, Ally DS, Sheahan MD, et al. Germline p16 mutations in familial melanoma. Nature Genet 1994; 8: 15-21.
26. Gruis NA, Van der Velden PA, Sandkuijl LA, Prins D, Weaver-Feldhaus J, Kamb A, et al. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nature Genet 1995; 10: 351-3.
27. Valverde P, Healy K, Jackson I, Rees JK, Thody AJ. Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nature Genet 1995; 11: 328-30.
28. Box NF, Wyeth JR, O'Gorman LE, Martin NG, Sturm RA. Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair. Hum Mol Genet 1997; 6: 1891-7.
29. Valverde P, Haely E, Sikkink S, Haldane F, Thody AJ, Carothers A, et al. The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma. Hum Mol Genet 1996; 5: 1663-6.
30. Van der Velden PA, Gruis NA, Pavel S, Sandkuijl KA, Bergman W, Frants RR. Melanocortin 1 receptor (MC1R) variant Arg151Cys and fair skin modify melanoma risk in Dutch melanoma families. Hum Mol Genet (submitted).
31. Zuo L, Weger J, Yang Q, Goldstein AM, Tucker MA, Walker GJ, et al. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nature Genet 1996; 12: 97-9.
32. Quelle DE, Zindy F, Ashmun RA, Sherr CJ. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 1995; 83: 993-1000.